TR200000384T2 - Oligonükleotitlerin çözelti fazlı sentezi. - Google Patents

Oligonükleotitlerin çözelti fazlı sentezi.

Info

Publication number
TR200000384T2
TR200000384T2 TR2000/00384T TR200000384T TR200000384T2 TR 200000384 T2 TR200000384 T2 TR 200000384T2 TR 2000/00384 T TR2000/00384 T TR 2000/00384T TR 200000384 T TR200000384 T TR 200000384T TR 200000384 T2 TR200000384 T2 TR 200000384T2
Authority
TR
Turkey
Prior art keywords
oligonucleotides
solution
phase synthesis
oligonucleotide
provides
Prior art date
Application number
TR2000/00384T
Other languages
English (en)
Turkish (tr)
Inventor
Bernard Reese Colin
Song Quanlai
Original Assignee
Avecia Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Avecia Limited filed Critical Avecia Limited
Publication of TR200000384T2 publication Critical patent/TR200000384T2/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00Processes for the preparation of sugar derivatives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D265/00Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/281,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/301,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings
    • C07D265/321,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings with oxygen atoms directly attached to ring carbon atoms
    • C07D265/33Two oxygen atoms, in positions 3 and 5
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/46Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with hetero atoms directly attached to the ring nitrogen atom
    • C07D207/48Sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/06Phosphorus compounds without P—C bonds
    • C07F9/16Esters of thiophosphoric acids or thiophosphorous acids
    • C07F9/165Esters of thiophosphoric acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/06Phosphorus compounds without P—C bonds
    • C07F9/16Esters of thiophosphoric acids or thiophosphorous acids
    • C07F9/165Esters of thiophosphoric acids
    • C07F9/18Esters of thiophosphoric acids with hydroxyaryl compounds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H11/00Compounds containing saccharide radicals esterified by inorganic acids; Metal salts thereof
    • C07H11/04Phosphates; Phosphites; Polyphosphates
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06Pyrimidine radicals
    • C07H19/10Pyrimidine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16Purine radicals
    • C07H19/20Purine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • C07H21/04Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids with deoxyribosyl as saccharide radical
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
TR2000/00384T 1997-08-13 1998-08-10 Oligonükleotitlerin çözelti fazlı sentezi. TR200000384T2 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9717158.1A GB9717158D0 (en) 1997-08-13 1997-08-13 Solution synthesis of oligonucleotides and their phosphorothioate analogues

Publications (1)

Publication Number Publication Date
TR200000384T2 true TR200000384T2 (tr) 2000-11-21

Family

ID=10817430

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2000/00384T TR200000384T2 (tr) 1997-08-13 1998-08-10 Oligonükleotitlerin çözelti fazlı sentezi.

Country Status (21)

Country Link
US (3) US6506894B1 (ref)
EP (2) EP1003758B1 (ref)
JP (1) JP2001515086A (ref)
KR (1) KR20010022840A (ref)
CN (1) CN1231492C (ref)
AT (1) ATE236916T1 (ref)
BR (1) BR9811166A (ref)
CA (1) CA2300874A1 (ref)
DE (1) DE69813243T2 (ref)
DK (1) DK1003758T3 (ref)
EA (1) EA003091B1 (ref)
ES (1) ES2197491T3 (ref)
GB (1) GB9717158D0 (ref)
HU (1) HUP0002684A3 (ref)
IL (1) IL134517A (ref)
IN (1) IN190784B (ref)
NO (1) NO20000690L (ref)
NZ (1) NZ502684A (ref)
PL (1) PL338888A1 (ref)
TR (1) TR200000384T2 (ref)
WO (1) WO1999009041A2 (ref)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9924285D0 (en) * 1999-10-14 1999-12-15 Avecia Ltd Process
GB0004889D0 (en) * 2000-03-01 2000-04-19 Avecia Ltd Synthesis of oligonucleotides
AU2002339175A1 (en) * 2001-11-21 2003-06-10 Avecia Biotechnology Inc. Coupling reagent for h-phosphonate chemistry
CA2477039A1 (en) * 2002-02-22 2003-09-04 Honeywell International Inc. Methods of producing phosphitylated compounds
GB0209539D0 (en) * 2002-04-26 2002-06-05 Avecia Ltd Monomer Polymer and process
WO2005077966A1 (en) * 2004-02-10 2005-08-25 Isis Pharmaceuticals, Inc. Substituted pixyl protecting groups for oligonucleotide synthesis
SG171914A1 (en) 2008-12-02 2011-07-28 Chiralgen Ltd Method for the synthesis of phosphorus atom modified nucleic acids
US8272150B2 (en) * 2008-12-12 2012-09-25 Speedplay, Inc. Shoe sole mounting standard for bicycle cleat
WO2010072831A1 (en) 2008-12-23 2010-07-01 Girindus America, Inc Sulfurizing reagents and their use for oligonucleotides synthesis
EP2451461A4 (en) 2009-07-06 2013-05-29 Ontorii Inc NOVEL NUCLEIC ACID PRODRUGS AND METHOD OF USE THEREOF
KR20130029108A (ko) 2010-06-30 2013-03-21 기린두스 아메리카 인코포레이티드 올리고뉴클레오타이드 합성을 위한 n-thio 화합물의 새로운 사용 방법
DK2620428T3 (da) 2010-09-24 2019-07-01 Wave Life Sciences Ltd Asymmetrisk hjælpegruppe
US9605019B2 (en) 2011-07-19 2017-03-28 Wave Life Sciences Ltd. Methods for the synthesis of functionalized nucleic acids
WO2013017469A1 (en) 2011-07-29 2013-02-07 Girindus America, Inc. Sulfurization reagents on solid supports
DK2872485T3 (da) 2012-07-13 2021-03-08 Wave Life Sciences Ltd Asymmetrisk hjælpegruppe
CN112007045B (zh) 2012-07-13 2026-01-06 波涛生命科学有限公司 手性控制
JP6246121B2 (ja) 2012-07-13 2017-12-13 株式会社新日本科学 キラル核酸アジュバント
WO2014085471A1 (en) * 2012-11-28 2014-06-05 Prognosdx Health, Inc. Acid-activated compositions for the treatment of cancers, methods of their use and methods of their preparation
WO2015108048A1 (ja) 2014-01-15 2015-07-23 株式会社新日本科学 抗腫瘍作用を有するキラル核酸アジュバンド及び抗腫瘍剤
US10322173B2 (en) 2014-01-15 2019-06-18 Shin Nippon Biomedical Laboratories, Ltd. Chiral nucleic acid adjuvant having anti-allergic activity, and anti-allergic agent
EP3095461A4 (en) 2014-01-15 2017-08-23 Shin Nippon Biomedical Laboratories, Ltd. Chiral nucleic acid adjuvant having immunity induction activity, and immunity induction activator
KR102423317B1 (ko) 2014-01-16 2022-07-22 웨이브 라이프 사이언시스 리미티드 키랄 디자인
WO2018215049A1 (en) * 2017-05-23 2018-11-29 F. Hoffmann-La Roche Ag Process for galnac oligonucleotide conjugates

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3444300A (en) * 1964-05-05 1969-05-13 Chevron Res N-polyhaloalkylthio compounds as fungicidal agents
FR1519704A (fr) * 1967-02-14 1968-04-05 Roussel Uclaf Nouveaux composés dithiocarbamiques hétérocycliques et procédé de préparation
US3546185A (en) 1968-03-20 1970-12-08 Monsanto Co Inhibiting premature vulcanization of diene rubbers
US5149798A (en) * 1989-04-06 1992-09-22 Worcester Foundation For Experimental Biology Process for synthesizing oligonucleotides and their analogs adaptable to large scale syntheses
EP0678096B1 (en) * 1993-01-08 1997-03-19 HYBRIDON, Inc. Synthesis of dimmer blocks and their use in assembling oligonucleotides
GB9501465D0 (en) * 1995-01-25 1995-03-15 King S College London Nucleoside phosphorothioate derivatives,synthesis and use thereof
GB0004889D0 (en) * 2000-03-01 2000-04-19 Avecia Ltd Synthesis of oligonucleotides

Also Published As

Publication number Publication date
US20050240015A1 (en) 2005-10-27
DE69813243T2 (de) 2004-01-29
KR20010022840A (ko) 2001-03-26
HUP0002684A2 (hu) 2000-12-28
US7019127B2 (en) 2006-03-28
NO20000690D0 (no) 2000-02-11
PL338888A1 (en) 2000-11-20
EP1003758A2 (en) 2000-05-31
JP2001515086A (ja) 2001-09-18
EP1325927A2 (en) 2003-07-09
DK1003758T3 (da) 2003-07-21
IL134517A (en) 2004-02-19
BR9811166A (pt) 2000-07-25
US20030083490A1 (en) 2003-05-01
EP1003758B1 (en) 2003-04-09
CN1274361A (zh) 2000-11-22
EA003091B1 (ru) 2002-12-26
US6506894B1 (en) 2003-01-14
IN190784B (ref) 2003-08-23
GB9717158D0 (en) 1997-10-22
HUP0002684A3 (en) 2001-11-28
WO1999009041A3 (en) 1999-05-06
ES2197491T3 (es) 2004-01-01
CA2300874A1 (en) 1999-02-25
AU8738698A (en) 1999-03-08
NO20000690L (no) 2000-04-11
NZ502684A (en) 2002-12-20
WO1999009041A2 (en) 1999-02-25
CN1231492C (zh) 2005-12-14
ATE236916T1 (de) 2003-04-15
DE69813243D1 (de) 2003-05-15
EP1325927A3 (en) 2008-07-02
IL134517A0 (en) 2001-04-30
EA200000211A1 (ru) 2000-08-28
AU749343B2 (en) 2002-06-27

Similar Documents

Publication Publication Date Title
DE69921147D1 (de) Fsh mimetika zur behandlung von infertilität
DE69840748D1 (de) Verfahren zur zubereitung von antisense oligonukleotiden
BR9814374A (pt) Inibição de quinase raf usando uréias heterocìclicas substituìdas
DK1054860T3 (da) Proces for syntesen af 1,3-dioler
DE69937861D1 (de) Verwendung von Trägerkatalysatoren zur Umsetzung von organischen Verbindungen
ATE373105T1 (de) Verbindungen und methoden zum nachweis von biomolekülen
EP1027473A4 (en) Mini-batch process chamber
DE69403642D1 (de) 7-deazapurin modifizierte oligonukleotide
EP1009860A4 (en) INHIBITION OF THE RAS GENE USING ANTISENSE OLIGONUCLEOTIDES
DE69928667D1 (de) Nicht-peptide inhibitoren von vla-4 abhängiger zellbindung für die behandlung von entzündungen, autoimmune krankheiten und atemstörungen
ATE291427T1 (de) Verwendung von optisch reinem (+)-norcisapride für die behandlung des reizdarmsyndroms
NO965080D0 (no) Antisens oligonukleotidmodulering av genekspresjon
DE60009665D1 (de) Zusammensetzungen zur behandlung von entzündungsreaktionen
ATE342911T1 (de) Synthese von nukleosiden und polynukleotiden
DE69819998D1 (de) Verfahren zur chemischen Synthese von Oligonukleotiden
BR0110402A (pt) Compostos
ATE195320T1 (de) Neue polymerträger zur nukleinsäuresynthese
EP1123414A4 (en) ANTISENSE MODULATION OF THE EXPRESSION OF INTEGRIN ALPHA 4
DE69906856D1 (de) Methode für die Inhibition von Haarwuchs
AU5529398A (en) Method for the synthesis of nucleotide or oligonucleotide phosphoramidites
DE69731112D1 (de) Verfahren zur synthese von phosphorothioat-oligonukelotiden
ATE335091T1 (de) Bc200 rna, daraus abgeleitete proben und entsprechende anwendungen
IT1312304B1 (it) Procedimento per rigenerare scoria di desolforazione.
BR9706374A (pt) Processo para redução de inibidores de hibridização de ácido nucleico
EP1109825A4 (en) Improved process for the synthesis of oligonucleotides incorporating 2-aminoadenosine